Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment ; volume:131 ; number:1 ; day:15 ; month:5 ; year:2024 ; pages:63-76 ; date:7.2024
British journal of cancer ; 131, Heft 1 (15.5.2024), 63-76, 7.2024
- Creator
-
Masui, Hideyuki
Kawada, Kenji
Itatani, Yoshiro
Hirai, Hideyo
Nakanishi, Yuki
Kiyasu, Yoshiyuki
Hanada, Keita
Okamoto, Michio
Hirata, Wataru
Nishikawa, Yasuyo
Sugimoto, Naoko
Tamura, Takuya
Sakai, Yoshiharu
Obama, Kazutaka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-024-02710-x
- URN
-
urn:nbn:de:101:1-2409252107539.359063381333
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Masui, Hideyuki
- Kawada, Kenji
- Itatani, Yoshiro
- Hirai, Hideyo
- Nakanishi, Yuki
- Kiyasu, Yoshiyuki
- Hanada, Keita
- Okamoto, Michio
- Hirata, Wataru
- Nishikawa, Yasuyo
- Sugimoto, Naoko
- Tamura, Takuya
- Sakai, Yoshiharu
- Obama, Kazutaka
- SpringerLink (Online service)
Other Objects (12)
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy
Oxygen-supplied electrotherapy for enhanced photodynamic synergistic therapy overcomes hypoxia tumor microenvironment
Amplified intracellular Ca2+ for synergistic anti-tumor therapy of microwave ablation and chemotherapy
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy
Oxygen-supplied electrotherapy for enhanced photodynamic synergistic therapy overcomes hypoxia tumor microenvironment
Amplified intracellular Ca2+ for synergistic anti-tumor therapy of microwave ablation and chemotherapy
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy
Oxygen-supplied electrotherapy for enhanced photodynamic synergistic therapy overcomes hypoxia tumor microenvironment